Nagla Elmelegy
- Emerging prognostic biomarkers in non small cell lung cancer patients: Impact of treatment with nimesulide (COX-2 inhibitor) combined with chemotherapyBy Soad Abdel-Ghany, Nagla Elmelegy, Aliae Mohamed-Hussein and Randa HanaSoad Abdel-Ghany1Medical Biochemistry, Faculty of Medicine, Assiut University, Assiut, EgyptNagla Elmelegy1Medical Biochemistry, Faculty of Medicine, Assiut University, Assiut, EgyptAliae Mohamed-Hussein2Chest Dept., Assiut University Hospitals, Assiut, EgyptRanda Hana1Medical Biochemistry, Faculty of Medicine, Assiut University, Assiut, Egypt
- Potential angiogenic biomarkers in patients with non small cell lung cancer: Possible implicationsBy Soad Abdel Ghani, Nagla Elmelegy, Aliae Mohamed-Hussein and Randa HannaSoad Abdel Ghani1Biochemistry, Faculty of Medicine, Assiut, EgyptNagla Elmelegy1Biochemistry, Faculty of Medicine, Assiut, EgyptAliae Mohamed-Hussein1Biochemistry, Faculty of Medicine, Assiut, EgyptRanda Hanna1Biochemistry, Faculty of Medicine, Assiut, Egypt
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.